Summary of NICE guidance on treatment of type 2 diabetes.
Qtern contains a fixed-dose combination of saxagliptin and dapagliflozin for use in type II diabetes inadequately controlled by metformin and/or a sulfonylurea plus saxagliptin or dapagliflozin.
Metformin-containing products can now be used in patients with moderate renal impairment following a review of the evidence by the European Medicines Agency (EMA).
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.